Name | 7-Ethyl-10-(4-N-aminopentanoic acid)-1-piperidino)carbonyloxycamptothecin |
---|---|
Synonyms |
1-Piperidinecarboxylic acid, 4-[(4-carboxybutyl)amino]-, 1-[(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl] ester
5-{[1-({[(4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl]oxy}carbonyl)-4-piperidinyl]amino}pentanoic acid |
Description | RPR121056 (APC) is a metabolite of Irinotecan (CPT-11), which is generated by CYP3A4. Irinotecan (CPT-11) is an antineoplastic agent that inhibits topoisomerase type I, causing cell death, and is widely used in the treatment of colorectal cancer. Irinotecan also directly inhibits AChE[1]. |
---|---|
Related Catalog | |
Target |
Topoisomerase type I[1]; AChE[1] |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 953.5±65.0 °C at 760 mmHg |
Molecular Formula | C33H38N4O8 |
Molecular Weight | 618.677 |
Flash Point | 530.5±34.3 °C |
Exact Mass | 618.268982 |
PSA | 160.29000 |
LogP | 2.92 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.679 |
Storage condition | -20°C |